| P50 | author | Robin Yabroff | Q71719506 |
| P2093 | author name string | Stephen H Taplin | |
| | Rebecca Anhang Price | |
| | Caroline Cranos | |
| | Jane Zapka | |
| P2860 | cites work | The meaning of translational research and why it matters | Q28264016 |
| | Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology | Q28274937 |
| | Cancer statistics, 2007 | Q29547293 |
| | What is the most effective way to communicate results after endoscopy? | Q30483507 |
| | Association between radiologists' experience and accuracy in interpreting screening mammograms | Q33330999 |
| | Geographic variation and effect of area-level poverty rate on colorectal cancer screening | Q33377274 |
| | Is default from colposcopy a problem, and if so what can we do? A systematic review of the literature | Q33644598 |
| | Timely follow-up of abnormal diagnostic imaging test results in an outpatient setting: are electronic medical records achieving their potential? | Q34058738 |
| | Racial/ethnic disparities in time to follow-up after an abnormal mammogram | Q34141799 |
| | Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence | Q34173853 |
| | Improving adherence to abnormal Pap smear follow-up | Q34201224 |
| | Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions. | Q34226631 |
| | Self-report versus medical records for assessing cancer-preventive services delivery. | Q34232368 |
| | Does the chronic care model serve also as a template for improving prevention? | Q34491882 |
| | Systematic review: the long-term effects of false-positive mammograms | Q34615110 |
| | Harvard report on cancer prevention, volume 5: fulfilling the potential for cancer prevention: policy approaches | Q34645844 |
| | Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test | Q34741635 |
| | Present standards for cervical cancer screening | Q34793733 |
| | Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. | Q47617609 |
| | How gastroenterologists inform patients of results after lower endoscopy. | Q51352019 |
| | Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening in Ontario, Canada--a replication study. | Q51675062 |
| | Providing an endoscopy report to patients after a procedure: a low-cost intervention with high returns. | Q51895767 |
| | The effect of patient race and socio-economic status on physicians' perceptions of patients | Q56688987 |
| | HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice | Q56783286 |
| | Cervical Cancer in Women With Comprehensive Health Care Access: Attributable Factors in the Screening Process | Q60622481 |
| | Re: Breast Cancer Screening Comes Full Circle | Q60622482 |
| | A national survey of primary care physicians' methods for screening for fecal occult blood | Q64132638 |
| | The changing interface of primary and specialty care | Q71092852 |
| | Diagnostic testing following fecal occult blood screening in the elderly | Q73053935 |
| | The expanded Chronic Care Model: an integration of concepts and strategies from population health promotion and the Chronic Care Model | Q79365322 |
| | Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States) | Q82254795 |
| | Evaluation of abnormal mammography results and palpable breast abnormalities | Q35215923 |
| | Is the promise of cancer-screening programs being compromised? Quality of follow-up care after abnormal screening results. | Q35217580 |
| | Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening | Q35644704 |
| | Interventions to improve follow-up of abnormal findings in cancer screening | Q35664998 |
| | The future of research that promotes cancer screening | Q35865878 |
| | Interventions for patients, providers, and health care organizations | Q35871452 |
| | Towards better communication in cancer care: a framework for developing evidence-based interventions | Q35914537 |
| | Review article: Population screening for colorectal cancer | Q36321324 |
| | The interface of primary and oncology specialty care: from symptoms to diagnosis | Q36352753 |
| | Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care | Q36352783 |
| | Designing studies that would address the multilayered nature of health care | Q36352805 |
| | Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology | Q36411016 |
| | Physician-patient communication about colorectal cancer screening | Q36416846 |
| | Understanding barriers for adherence to follow-up care for abnormal pap tests | Q36793872 |
| | Interventions to enhance breast cancer screening, diagnosis, and treatment among racial and ethnic minority women | Q36946381 |
| | 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests | Q36955449 |
| | Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation | Q37060085 |
| | Organizational factors and the cancer screening process | Q37064290 |
| | Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues | Q37149717 |
| | Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population | Q37151365 |
| | Patient navigation: state of the art or is it science? | Q37185870 |
| | Client-directed interventions to increase community demand for breast, cervical, and colorectal cancer screening a systematic review | Q37186919 |
| | Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review | Q37186923 |
| | Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives | Q37186929 |
| | Barriers to diagnostic resolution after abnormal mammography: a review of the literature | Q37261264 |
| | Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears | Q37309782 |
| | Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis | Q37378606 |
| | Improving the quality of health care in the United Kingdom and the United States: a framework for change | Q38577543 |
| | Patient navigation and case management following an abnormal mammogram: a randomized clinical trial | Q39768162 |
| | Neighborhood-level socioeconomic predictors of nonadherence to mammography screening guidelines | Q39821822 |
| | Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. | Q39822160 |
| | From 'silent' to 'heard': professional mediation, manipulation and women's experiences of their body after an abnormal Pap smear | Q40018493 |
| | Association between health insurance coverage of office visit and cancer screening among women | Q40624002 |
| | Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening | Q40745960 |
| | A review of cervical cancer screening intervention research: implications for public health programs and future research | Q40869810 |
| | Improving the follow-up of patients with abnormal Papanicolaou smear results. | Q41643913 |
| | Innovative provider- and health system-directed approaches to improving colorectal cancer screening delivery | Q44220210 |
| | The effect of HEDIS measurement of colorectal cancer screening on insurance plans in Pennsylvania | Q44280160 |
| | Barriers to full colon evaluation for a positive fecal occult blood test | Q46329100 |
| P433 | issue | 40 | |
| P304 | page(s) | 58-71 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Journal of the National Cancer Institute Monographs | Q15756343 |
| P1476 | title | Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care | |
| P478 | volume | 2010 | |